Advertisement
U.S. markets closed

Navidea Biopharmaceuticals, Inc. (NAVB)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0450-0.0001 (-0.33%)
At close: 03:42PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0452
Open0.0403
Bid0.0000 x 800
Ask0.0000 x 1100
Day's Range0.0403 - 0.0499
52 Week Range0.0210 - 0.3428
Volume6,997
Avg. Volume191,727
Market Cap4.504M
Beta (5Y Monthly)1.14
PE Ratio (TTM)N/A
EPS (TTM)-0.2000
Earnings DateMar 19, 2024 - Mar 25, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NAVB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Navidea Biopharmaceuticals, Inc
    Daily – Vickers Top Buyers & Sellers for 02/21/2024The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more